SARS-CoV-2 3CLpro-IN-7
SARS-CoV-2 3CLpro-IN-7 is a reversible covalent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 1.4 μM[1].
Product Specifications
CAS Number
[1164478-67-4]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-7.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C([N+]([O-])=O)C=C1)COC(/C(NC(C2=CC=CC=C2)=O)=C/C3=CC=C(Cl)C=C3)=O
Molecular Formula
C24H17ClN2O6
Molecular Weight
464.85
References & Citations
[1]Wang L, et al. Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen. Eur J Med Chem. 2022 Dec 15;244:114803.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15129276 1 Vial
Lentiviral human POT1 shRNA (UAS) - Lentiviral human POT1 shRNA (UAS, RFP) (100)
Ask
View Details 
